Activation of retinal Müller cells in response to glucose variability.
Animals
Aquaporin 4
/ metabolism
Cell Cycle
/ drug effects
Cells, Cultured
Diabetic Retinopathy
Ependymoglial Cells
/ drug effects
Extracellular Signal-Regulated MAP Kinases
/ metabolism
Glial Fibrillary Acidic Protein
/ metabolism
Glucose
/ deficiency
Hyperglycemia
/ physiopathology
Neuroglia
/ drug effects
Rats
Retina
/ drug effects
Glucose variability
Müller cells activation
Retinal neurodegeneration
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
03
05
2019
accepted:
11
07
2019
pubmed:
22
7
2019
medline:
2
6
2020
entrez:
22
7
2019
Statut:
ppublish
Résumé
In the earliest stages of diabetic retinopathy (DR), a dysfunction of Müller cells, characterized by high levels of glial fibrillary acidic protein (GFAP), and aquaporins (AQP), has been observed. Although chronic hyperglycemia causes the activation of Müller cells, the effect of glycemic fluctuations is yet unknown. The aim of the study was to analyze the impact of glucose variability on rat retinal Müller cells (rMC-1) adapted to either normal (5 mM) or high (25 mM) glucose levels. rMC-1 were cultured in a medium containing either 5 mM (N cells) or 25 mM of glucose (H cells) and then incubated for 96 h in a medium containing (a) low glucose (either 1-3 or 5 mM), (b) basal glucose (either 5 or 25 mM), (c) high glucose (either 25 or 45 mM), (d) basal and high glucose alternated every 24 h; (e) low- and high glucose alternated every 24 h; (f) basal glucose with episodes of low glucose for 30 min twice a day. Müller cells activation was evaluated by measuring the levels of GFAP, AQP4, and phospho-active extracellular signal-regulated kinase (pERK). Under both basal and high glucose concentrations rMC-1 were viable, but their response to glucose excursions was different. In N cells kept under normal (5 mM) glucose, a significant glial activation was measured not only in response to constant high glucose but also to alternating low/high glucose. In H cells, adapted to 25 mM glucose, a significant response was observed only after exposition to a lower (5 mM) glucose concentration. Our results highlight Müller cells activation in response to glucose variability and a different susceptibility depending on the basal glucose conditions.
Identifiants
pubmed: 31327157
doi: 10.1007/s12020-019-02017-5
pii: 10.1007/s12020-019-02017-5
doi:
Substances chimiques
Aqp4 protein, rat
0
Aquaporin 4
0
GFAP protein, rat
0
Glial Fibrillary Acidic Protein
0
Extracellular Signal-Regulated MAP Kinases
EC 2.7.11.24
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
542-549Références
Clin Exp Ophthalmol. 2016 May;44(4):243-50
pubmed: 26872562
Bone Joint Res. 2018 Jun 5;7(5):362-372
pubmed: 29922457
Diabetes Res Clin Pract. 2014 Mar;103(3):e37-9
pubmed: 24456992
Diabetes. 2003 Nov;52(11):2795-804
pubmed: 14578299
J Biol Chem. 1986 Mar 25;261(9):4046-51
pubmed: 3949802
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):212-6
pubmed: 9430566
Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6645-54
pubmed: 22956616
Acta Diabetol. 2017 May;54(5):489-497
pubmed: 28238189
Exp Eye Res. 2014 Aug;125:20-9
pubmed: 24877742
Cells. 2012 Jul 27;1(3):372-95
pubmed: 24710481
Diabetes Res Clin Pract. 2011 Dec;94(3):e68-71
pubmed: 21906831
Diabetes. 2012 Feb;61(2):492-504
pubmed: 22228718
Ophthalmologica. 2012;227(1):1-19
pubmed: 21921569
Curr Diabetes Rev. 2012 Sep;8(5):345-54
pubmed: 22698079
Mol Vis. 2014 Oct 23;20:1463-70
pubmed: 25352752
Invest Ophthalmol Vis Sci. 2012 Jun 08;53(7):3481-9
pubmed: 22511624
J Biol Chem. 2009 Aug 7;284(32):21412-24
pubmed: 19520853
Hypertens Res. 2003 Jan;26(1):67-73
pubmed: 12661915
Vision Res. 2017 Oct;139:93-100
pubmed: 28866025
Mol Cell Biochem. 2010 Oct;343(1-2):27-35
pubmed: 20524146
Exp Eye Res. 2012 May;98:37-43
pubmed: 22449442
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Am J Physiol Cell Physiol. 2011 Nov;301(5):C1213-23
pubmed: 21832250
Eye Vis (Lond). 2015 Sep 30;2:17
pubmed: 26605370
Biochem Pharmacol. 2012 Oct 1;84(7):961-73
pubmed: 22796564
PLoS One. 2010 Apr 02;5(4):e9996
pubmed: 20368806
BMC Ophthalmol. 2018 Aug 6;18(1):192
pubmed: 30081847
PLoS One. 2013;8(2):e55456
pubmed: 23408985
Diabetes Metab Res Rev. 1999 Jul-Aug;15(4):261-73
pubmed: 10495475
Physiol Rev. 2013 Oct;93(4):1543-62
pubmed: 24137016
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3913-8
pubmed: 26087356
Cell Stress Chaperones. 2015 Jan;20(1):1-2
pubmed: 25300204
Ann N Y Acad Sci. 2014 Apr;1311:174-90
pubmed: 24673341
J Mol Endocrinol. 2010 Mar;44(3):179-85
pubmed: 20154025